STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy

被引:68
作者
Du, Wei [1 ]
Wang, Na [2 ]
Li, Fan [1 ]
Jia, Keqi [1 ]
An, Jiahui [1 ]
Liu, Yaping [1 ]
Wang, Yuxue [1 ]
Zhu, Lin [3 ]
Zhao, Song [1 ]
Hao, Jun [1 ]
机构
[1] Hebei Med Univ, Dept Pathol, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 2, Dept Pediat, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Hosp 3, Dept Electromyogram, Shijiazhuang, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
histone deacetylase 1; JAK-STAT3; signaling; Atg3; P62; LC3; INHIBITION; JAK/STAT; PATHWAY; HDAC1; BIOENERGETICS; PATHOGENESIS; MECHANISMS;
D O I
10.1096/fj.201900127R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Schwann cells are the main supportive cells of the peripheral nerves. Schwann cells suffer inhibition of autophagy under hyperglycemia treatment in diabetic peripheral neuropathy (DPN). However, the exact mechanism is still not fully elucidated. We first observed the decrease of autophagy markers (LC3-II/LC3-I, P62) in the sciatic nerves of diabetic mice vs. normal mice, accompanied with the loss of myelinated nerve fibers and abnormal myelin sheath. In line with this, LC3-II/LC3-I and P62 were also significantly reduced in high glucose-treated rat Schwann cell 96 (RSC96) cells compared with normal glucose-treated cells. Furthermore, we found that trichostatin A [an inhibitor of histone deacetylase (HDAC)] evidently improved LC3-II/LC3-I in high glucose-treated RSC96 cells, without an effect on P62 expression. Again, HDAC1 and HDAC5 were revealed to be increased in RSC96 cells stimulated with high glucose. Inhibition of HDAC1 but not HDAC5 by small hairpin RNA vector enhanced LC3-II/LC3-I in high glucose-cultured RSC96 cells. In addition, LC3-II conversion regulators [autophagy-related protein (Atg)3, Atg5, and Atg7] were detected in high glucose-treated and HDAC1-knockdown RSC96 cells, and Atg3 was proven to be the key target of HDAC1. The presuppression of Atg3 offset the improvement of LC3-II/LC3-I resulting from HDAC1 inhibition in high glucose-treated RSC96 cells. The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway was activated in RSC96 cells treated with high glucose, which was indicated by increased STAT3 phosphorylation. Blocking STAT3 phosphorylation by chemical inhibitor AG490 induced HDAC1 down-regulation followed by increases in Atg3 and LC3-II/LC3-I. Interestingly, we also found that AG490 treatment enhanced P62 expression in high glucose-stimulated RSC96 cells. Taken together, our findings demonstrate that hyperglycemia inhibits LC3-II/LC3-I in an HDAC1-Atg3-dependent manner and decreases P62 expression in an HDAC-independent manner via the JAK-STAT3 signaling pathway in the Schwann cells of DPN.-Du, W., Wang, N., Li, F. Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Zhao, S. Hao, J. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy.
引用
收藏
页码:8008 / 8021
页数:14
相关论文
共 42 条
  • [1] Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
    Al-Rasheed, Nouf M.
    Al-Rasheed, Nawal M.
    Hasan, Iman H.
    Al-Amin, Maha A.
    Al-Ajmi, Hanaa N.
    Mahmoud, Ayman M.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2095 - 2107
  • [2] Epigenetic protein families: a new frontier for drug discovery
    Arrowsmith, Cheryl H.
    Bountra, Chas
    Fish, Paul V.
    Lee, Kevin
    Schapira, Matthieu
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (05) : 384 - 400
  • [3] Bai Y, 2018, FASEB J, V32, P4573, DOI [10.1096/fj.201701411R, 10.1096/fj.201701411r]
  • [4] Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats
    Candeias, Emanuel
    Sebastiao, Ines
    Cardoso, Susana
    Carvalho, Cristina
    Santos, Maria Sancha
    Oliveira, Catarina Resende
    Moreira, Paula I.
    Duarte, Ana I.
    [J]. MOLECULAR NEUROBIOLOGY, 2018, 55 (05) : 4030 - 4050
  • [5] Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
    Cao, Dian J.
    Wang, Zhao V.
    Battiprolu, Pavan K.
    Jiang, Nan
    Morales, Cyndi R.
    Kong, Yongli
    Rothermel, Beverly A.
    Gillette, Thomas G.
    Hill, Joseph A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (10) : 4123 - 4128
  • [6] DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells
    Cheng, Meijuan
    Lv, Xin
    Zhang, Cuihong
    Du, Wei
    Liu, Yaping
    Zhu, Lin
    Hao, Jun
    [J]. NEUROCHEMICAL RESEARCH, 2018, 43 (11) : 2141 - 2154
  • [7] Ciliary Neurotrophic Factor Reverses Aberrant Mitochondrial Bioenergetics Through the JAK/STAT Pathway in Cultured Sensory Neurons Derived from Streptozotocin-Induced Diabetic Rodents
    Chowdhury, Subir Roy
    Saleh, Ali
    Akude, Eli
    Smith, Darrell R.
    Morrow, Dwane
    Tessler, Lori
    Calcutt, Nigel A.
    Fernyhough, Paul
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2014, 34 (05) : 643 - 649
  • [8] Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy
    Chung, You Chul
    Lim, Ji Hee
    Oh, Hyun Mi
    Kim, Hyung Wook
    Kim, Min Young
    Kim, Eun Nim
    Kim, Yaeni
    Chang, Yoon Sik
    Kim, Hye Won
    Park, Cheol Whee
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [9] Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress
    Dehdashtian, Ehsan
    Mehrzadi, Saeed
    Yousefi, Bahman
    Hosseinzadeh, Azam
    Reiter, Russel J.
    Safa, Majid
    Ghaznavi, Habib
    Naseripour, Masood
    [J]. LIFE SCIENCES, 2018, 193 : 20 - 33
  • [10] JAK/STAT - Emerging Players in Metabolism
    Dodington, David W.
    Desai, Harsh R.
    Woo, Minna
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (01) : 55 - 65